BRCA1/BRCA2 Gene Analysis NGS

• Comprehensive Genetic Testing: The BRCA1/BRCA2 Gene Analysis NGS Test uses next-generation sequencing (NGS) to identify mutations in the BRCA1 and BRCA2 genes.
• Cancer Risk Assessment: Detects genetic variations associated with an increased risk of breast and ovarian cancers.
• High Precision: Utilizes advanced sequencing technology for accurate detection of small mutations, deletions, and duplications.

• Risk Evaluation: Assesses the risk of developing breast and ovarian cancers by identifying mutations in BRCA1 and BRCA2 genes.
• Family Planning: Informs family members about their potential genetic risk and guides preventive measures.
• Treatment Decisions: Helps in tailoring personalized treatment plans for individuals with known BRCA1/BRCA2 mutations.
• Screening and Prevention: Supports regular screening and preventive strategies for individuals at high genetic risk.

• Sample Collection Kit: Provides materials for collecting blood or saliva samples.
• Detailed Instructions: Step-by-step guidelines for proper sample collection and preparation.
• NGS Analysis: Comprehensive next-generation sequencing to detect mutations, deletions, and duplications in BRCA1 and BRCA2 genes.
• Result Reporting: Detailed report with genetic findings, interpretations, and clinical recommendations.

• Positive Result: Indicates the presence of mutations in BRCA1 or BRCA2 genes, suggesting an increased risk for breast and ovarian cancers.
• Negative Result: No significant mutations were detected, suggesting a lower risk of hereditary breast and ovarian cancers.
• Variant of Uncertain Significance (VUS): Identifies genetic changes whose impact on cancer risk is not yet clear.
• Clinical Recommendations: Provides guidance on further testing, screening, or preventive measures based on the results.

• Turnaround Time: Results are typically available within 2-3 weeks after the sample is received.
• Secure Online Access: Results can be accessed through a secure online portal for both patients and healthcare providers.
• Detailed Reporting: Includes comprehensive analysis and clear interpretation of genetic findings.
• Follow-Up Recommendations: Suggestions for additional testing, preventive strategies, or treatment options based on results.

Q. What is the BRCA1/BRCA2 Gene Analysis NGS Test?
It’s a genetic test that uses next-generation sequencing to identify mutations in the BRCA1 and BRCA2 genes linked to higher risks of breast and ovarian cancers
 

Q. Why should I take this test?
This test helps assess your risk for developing breast and ovarian cancers and informs preventive measures and treatment plans
 

Q. How is the sample collected?
A blood or saliva sample is collected using the provided kit and following the detailed instructions
 

Q. How long does it take to get the results?
Results are typically available within 2-3 weeks after the lab receives your sample
 

Q. What does a positive result mean?
A positive result means that mutations in the BRCA1 or BRCA2 genes were found, indicating an increased risk of breast and ovarian cancers
 

Q. What does a negative result mean?
A negative result means no significant mutations were detected in the BRCA1 or BRCA2 genes, suggesting a lower risk of hereditary breast and ovarian cancers
 

Q. What should I do if my result shows a variant of uncertain significance (VUS)?
Consult your healthcare provider to discuss the findings and consider additional testing or monitoring as needed